Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    19134016 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Safety and Efficacy of Ultra-Rush Sublingual Immunotherapy in Children With Asthma Allergic to Grass Pollen
Condition: Asthma
Interventions: Drug: Staloral 300;   Drug: placebo

Indicates status has not been verified in more than two years